Tianjin Tianyao Pharmaceuticals Co Ltd Total Assets
Tianjin Tianyao Pharmaceuticals Co Ltd total assets. Based on the latest financial reports, Tianjin Tianyao Pharmaceuticals Co Ltd (600488) holds total assets worth CN¥5.74 Billion CNY (≈ $840.40 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is Tianjin Tianyao Pharmaceuticals Co Ltd worth for the company's overall valuation and market capitalisation.
Total Assets of Tianjin Tianyao Pharmaceuticals Co Ltd (1998–2024)
Total assets of Tianjin Tianyao Pharmaceuticals Co Ltd from 1998 to 2024. This chart illustrates how Tianjin Tianyao Pharmaceuticals Co Ltd's total assets have evolved over time, based on quarterly financial data. See current stock price of Tianjin Tianyao Pharmaceuticals Co Ltd for real-time trading data and today's change.
Tianjin Tianyao Pharmaceuticals Co Ltd - Asset Composition Analysis
Tianjin Tianyao Pharmaceuticals Co Ltd Total Assets Breakdown (December 2024)
Tianjin Tianyao Pharmaceuticals Co Ltd total assets breakdown as of December 2024. Tianjin Tianyao Pharmaceuticals Co Ltd's total assets of CN¥5.74 Billion consist of 31.7% current assets and 68.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 11.2% |
| Accounts Receivable | CN¥484.33 Million | 8.5% |
| Inventory | CN¥651.92 Million | 11.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥530.57 Million | 9.3% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (1998–2024)
This chart illustrates how Tianjin Tianyao Pharmaceuticals Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Tianjin Tianyao Pharmaceuticals Co Ltd current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tianjin Tianyao Pharmaceuticals Co Ltd's current assets represent 31.7% of total assets in 2024, a decrease from 62.0% in 1998.
- Cash Position: Cash and equivalents constituted 11.2% of total assets in 2024, up from 6.6% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 0.0% in 1998.
- Asset Diversification: The largest asset category is inventory at 11.4% of total assets.
Tianjin Tianyao Pharmaceuticals Co Ltd Competitors by Total Assets
Key competitors of Tianjin Tianyao Pharmaceuticals Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Turk Ilac ve Serum Sanayi AS
IS:TRILC
|
Turkey | TL6.12 Billion |
|
Wockhardt Limited
NSE:WOCKPHARMA
|
India | Rs81.35 Billion |
|
PharmaBlock Sciences Nanjing Inc Class A
SHE:300725
|
China | CN¥5.38 Billion |
|
AptaBio Therapeutics Inc
KQ:293780
|
Korea | ₩67.12 Billion |
|
Canopy Growth Corp
NASDAQ:CGC
|
USA | $1.10 Billion |
|
Zhejiang Nhu Co Ltd
SHE:002001
|
China | CN¥47.45 Billion |
|
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS
IS:ECILC
|
Turkey | TL70.69 Billion |
|
Jiangzhong Pharmaceutical Co Ltd
SHG:600750
|
China | CN¥6.74 Billion |
Tianjin Tianyao Pharmaceuticals Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.74 | 1.48 | 1.04 |
| Quick Ratio | 1.19 | 0.95 | 0.43 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥846.27 Million | CN¥682.52 Million | CN¥81.03 Million |
Tianjin Tianyao Pharmaceuticals Co Ltd - Advanced Valuation Insights
This section examines the relationship between Tianjin Tianyao Pharmaceuticals Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.50 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | -7.2% |
| Total Assets | CN¥5.70 Billion |
| Market Capitalization | $787.70 Million USD |
Valuation Analysis
Below Book Valuation: The market values Tianjin Tianyao Pharmaceuticals Co Ltd's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Tianjin Tianyao Pharmaceuticals Co Ltd's assets decreased by 7.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Tianjin Tianyao Pharmaceuticals Co Ltd (1998–2024)
The table below shows the annual total assets of Tianjin Tianyao Pharmaceuticals Co Ltd from 1998 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥5.70 Billion ≈ $833.84 Million |
-7.23% |
| 2023-12-31 | CN¥6.14 Billion ≈ $898.84 Million |
-7.64% |
| 2022-12-31 | CN¥6.65 Billion ≈ $973.21 Million |
+4.82% |
| 2021-12-31 | CN¥6.35 Billion ≈ $928.48 Million |
+2.74% |
| 2020-12-31 | CN¥6.18 Billion ≈ $903.75 Million |
+16.94% |
| 2019-12-31 | CN¥5.28 Billion ≈ $772.80 Million |
+10.01% |
| 2018-12-31 | CN¥4.80 Billion ≈ $702.46 Million |
+12.08% |
| 2017-12-31 | CN¥4.28 Billion ≈ $626.74 Million |
+42.69% |
| 2016-12-31 | CN¥3.00 Billion ≈ $439.25 Million |
-1.04% |
| 2015-12-31 | CN¥3.03 Billion ≈ $443.85 Million |
+4.71% |
| 2014-12-31 | CN¥2.90 Billion ≈ $423.89 Million |
-6.90% |
| 2013-12-31 | CN¥3.11 Billion ≈ $455.32 Million |
+24.87% |
| 2012-12-31 | CN¥2.49 Billion ≈ $364.65 Million |
+3.11% |
| 2011-12-31 | CN¥2.42 Billion ≈ $353.64 Million |
-17.23% |
| 2010-12-31 | CN¥2.92 Billion ≈ $427.25 Million |
+11.29% |
| 2009-12-31 | CN¥2.62 Billion ≈ $383.90 Million |
+2.01% |
| 2008-12-31 | CN¥2.57 Billion ≈ $376.34 Million |
+11.08% |
| 2007-12-31 | CN¥2.32 Billion ≈ $338.81 Million |
-4.53% |
| 2006-12-31 | CN¥2.43 Billion ≈ $354.90 Million |
+22.61% |
| 2005-12-31 | CN¥1.98 Billion ≈ $289.45 Million |
+29.40% |
| 2004-12-31 | CN¥1.53 Billion ≈ $223.68 Million |
-4.76% |
| 2003-12-31 | CN¥1.60 Billion ≈ $234.85 Million |
+13.10% |
| 2002-12-31 | CN¥1.42 Billion ≈ $207.65 Million |
+25.13% |
| 2001-12-31 | CN¥1.13 Billion ≈ $165.94 Million |
+125.55% |
| 2000-12-31 | CN¥502.78 Million ≈ $73.57 Million |
+22.40% |
| 1999-12-31 | CN¥410.77 Million ≈ $60.11 Million |
+41.68% |
| 1998-12-31 | CN¥289.93 Million ≈ $42.43 Million |
-- |
About Tianjin Tianyao Pharmaceuticals Co Ltd
Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. The company's primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid r… Read more